Iok-Hou Pang, PhD
Professor of Pharmaceutical Sciences
Education & Experience:
I received a BS in Pharmacy from the National Defense Medical Center in Taipei, Taiwan, and a PhD in Pharmacology from the University of Texas Southwestern Medical Center in Dallas, Texas, where I also completed my postdoctoral training in Molecular Pharmacology. I was a research scientist at Alcon Laboratories for more than 20 years, specializing in disease mechanism and new drug discovery. From 2008 to July 2012, I was the Director and Head of Glaucoma Research. I joined UNTHSC in 2012 and served as the Founding Chair of the Department of Pharmaceutical Sciences
Teaching Areas & Interests:
I teach Pharm.D. students mainly Physiology and Pharmacology (especially Endocrine and Neuropharmacology). I teach graduate students Visual Sciences. I also mentor Ph.D. students and serve on their exam and dissertation committees.
Professional Activities & Awards:
I am a member of numerous professional organizations, including the American Association of Pharmaceutical Scientists, Association for Research in Vision and Ophthalmology, Association of Ocular Pharmacology and Therapeutics, International Society for Eye Research, and Society for Neuroscience. I have served on editorial boards and as reviewer for several journals. I am an inventor in 18 issued US & international patent families and numerous pending patents.
I have considerable experience in glaucoma research and ocular pharmacology. I have been involved in glaucoma drug discovery since 1990 and dedicated in evaluation and discovery of new potential therapeutic targets and agents for the disease. My current research interests mainly focus on the understanding of glaucoma etiology, pathology, and pharmacology, especially on glaucoma neuroprotection. I am working to delineate essential molecular and cellular mechanisms, as well as characterize receptors and signal transduction pathways related to the abnormal changes in glaucoma. My laboratory is using rodents and primary cultures of retinal cells, neurons as well as glias, as study models to clarify biological events leading to glaucomatous retinopathy and its prevention and protection. I have edited one book and coauthored more than 100 peer-reviewed publications and book chapters.
This page was last modified on October 4, 2018